Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -133,816 | -121,755 | -78,996 | -36,168 | 46,383 |
| Depreciation Amortization | -485 | 4,144 | 5,450 | 3,948 | -1,078 |
| Income taxes - deferred | N/A | N/A | 345 | 10,608 | -3,138 |
| Accounts receivable | 11,704 | 3,258 | -84 | 27,821 | 15,892 |
| Accounts payable and accrued liabilities | -1,151 | -4,634 | 3,774 | -883 | 1,791 |
| Other Working Capital | 8,024 | 6,789 | -13,688 | 12,900 | 11,491 |
| Other Operating Activity | 12,570 | 27,416 | 13,203 | -11,138 | 77 |
| Operating Cash Flow | $-103,154 | $-84,782 | $-69,996 | $7,088 | $71,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,058 | -2,125 | -750 | -1,445 | -5,417 |
| Purchase Of Investment | -373,391 | -171,446 | -307,348 | -338,553 | -549,312 |
| Sale Of Investment | 328,871 | 228,468 | 345,089 | 359,828 | 468,065 |
| Investing Cash Flow | $-53,578 | $54,897 | $36,991 | $19,830 | $-86,664 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -86 |
| Common Stock Issued | 2,208 | 21,262 | 3,614 | 10,481 | 6,848 |
| Other Financing Activity | 195,918 | -1,229 | -534 | -1,498 | -4,188 |
| Financing Cash Flow | $198,126 | $20,033 | $3,080 | $8,983 | $2,574 |
| Beginning Cash Position | 47,962 | 57,814 | 87,739 | 51,838 | 64,510 |
| End Cash Position | 89,356 | 47,962 | 57,814 | 87,739 | 51,838 |
| Net Cash Flow | $41,394 | $-9,852 | $-29,925 | $35,901 | $-12,672 |
| Free Cash Flow | |||||
| Operating Cash Flow | -103,154 | -84,782 | -69,996 | 7,088 | 71,418 |
| Capital Expenditure | -9,058 | -2,125 | -750 | -1,445 | -5,417 |
| Free Cash Flow | -112,212 | -86,907 | -70,746 | 5,643 | 66,001 |